Advertisement
For patients with COVID-19 requiring hospitalization

Hydroxychloroquine Plus Macrolides No Benefit in COVID-19

0
Hydroxychloroquine, chloroquine with or without macrolides linked to in-hospital mortality, arrhythmia
For adults hospitalized with COVID-19 with lower respiratory tract infection

Remdesivir Beats Placebo for Time to COVID-19 Recovery

0
Researchers suggest antiviral agents in combination with other therapeutic approaches may further improve outcomes
The World Health Organization has suspended use of the antimalarial drug hydroxychloroquine in a clinical trial of treatments of COVID-19 after a study revealed that patients taking the drug are at increased risk for death and serious heart problems.

WHO Suspends Testing of Hydroxychloroquine in COVID-19 Patients

0
In light of recent findings, hydroxychloroquine arm of WHO global study paused temporarily
A chest X-ray severity score can predict outcomes among young and middle-aged adults with COVID-19 on presentation to the emergency department

ED Chest X-Ray Score Predicts COVID-19 Outcomes in Adults <50

0
CXR severity score ≥2 and obesity independent predictors of hospital admission
Children may experience acute cardiac decompensation due to a severe inflammatory state (multisystem inflammatory syndrome in children) following infection with severe acute respiratory syndrome coronavirus 2

Cardiac Decompensation Seen in Children Following COVID-19

0
Cardiac decompensation occurred in conjunction with multisystem inflammatory syndrome in some children
In Northern California

Incidence of AMI Hospitalization Down During COVID-19

0
Decrease seen in incidence of STEMI, NSTEMI in Northern California during COVID-19 period versus pre-COVID-19
At the Cedars-Sinai Medical Center in Los Angeles

No SARS-CoV-2 ID’d in Asymptomatic Pregnant Women in Los Angeles

0
Among 80 asymptomatic pregnant women admitted to Cedars-Sinai Medical Center, none tested positive
Modest delays in cancer surgery due to the COVID-19 pandemic could have a significant impact on survival

Delays in Cancer Surgery Due to COVID-19 Could Harm Survival

0
Per-patient delay of three or six months would result in an estimated 92,214 or 208,275 life-years lost
The U.S. Department of Health and Human Services said Thursday it would provide up to $1.2 billion to AstraZeneca to develop a potential COVID-19 vaccine from a lab in Oxford

U.S. Offers $1.2 Billion to Drug Company for COVID-19 Vaccine Research

0
Deal will fund phase 3 clinical trial in the United States this summer with about 30,000 volunteers
Older age

Age, Sex, History of Diabetes Predict Intubation in COVID-19

0
Only factors independently associated with time to extubation are age and body mass index